Dose-dependent regression of HeLa cell-derived tumours in SCID mice after parvovirus H-1 infection.
Parvoviruses of rodents are endowed with oncosuppressive properties. In particular, parvoviral infections protect host animals from spontaneous and chemical- or virus-induced tumour initiation in laboratory animals. The present study was undertaken to substantiate the capacity of parvovirus H-1 to inhibit therapeutically the growth of established tumours originating from human carcinoma cells implanted in recipient mice. To this end, quickly growing s.c. carcinomas were established by injection of human cervical carcinoma cells (HeLa) into immunodeficient (SCID) mice. Tumour-bearing mice subsequently were inoculated with H-1 at various multiplicities of infection. H-1 virus infection led to regression of tumours, the onset and efficiency of which were dose-dependent.
Faisst
S
S
Tumour Virology Unit and INSERM U 375, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
Guittard
D
D
Benner
A
A
Cesbron
J Y
JY
Schlehofer
J R
JR
Rommelaere
J
J
Dupressoir
T
T
D000818:Animals; D006367:HeLa Cells; D006801:Humans; D007150:Immunohistochemistry; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D009374:Neoplasms, Experimental / Q000473:pathology / Q000821:virology*; D010322:Parvoviridae Infections / Q000150:complications*; D017361:Viral Nonstructural Proteins / Q000378:metabolism
D017361:Viral Nonstructural Proteins